1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Matsuo Y, Sawai H, Ochi N, Yasuda A,
Sakamoto M, Takahashi H, Funahashi H, Takeyama H and Guha S:
Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic
cancer by blocking NF-kappaB activity. Dig Dis Sci. 55:1167–1176.
2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Enomoto A, Murakami H, Asai N, Morone N,
Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K and
Takahashi M: Akt/PKB regulates actin organization and cell motility
via Girdin/APE. Dev Cell. 9:389–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Omori K, Asai M, Kuga D, Ushida K, Izuchi
T, Mii S, Enomoto A, Asai N, Nagino M and Takahashi M: Girdin is
phosphorylated on tyrosine 1798 when associated with structures
required for migration. Biochem Biophys Res Commun. 458:934–940.
2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yamamura Y, Asai N, Enomoto A, Kato T, Mii
S, Kondo Y, Ushida K, Niimi K, Tsunoda N, Nagino M, et al:
Akt-Girdin signaling in cancer-associated fibroblasts contributes
to tumor progression. Cancer Res. 75:813–823. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kitamura T, Asai N, Enomoto A, Maeda K,
Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, et al:
Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate
Girdin. Nat Cell Biol. 10:329–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ito T, Komeima K, Yasuma T, Enomoto A,
Asai N, Asai M, Iwase S, Takahashi M and Terasaki H: Girdin and its
phosphorylation dynamically regulate neonatal vascular development
and pathological neovascularization in the retina. Am J Pathol.
182:586–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Enomoto A, Ping J and Takahashi M: Girdin,
a novel actin-binding protein, and its family of proteins possess
versatile functions in the Akt and Wnt signaling pathways. Ann N Y
Acad Sci. 1086:169–184. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Anai M, Shojima N, Katagiri H, Ogihara T,
Sakoda H, Onishi Y, Ono H, Fujishiro M, Fukushima Y, Horike N, et
al: A novel protein kinase B (PKB)/AKT-binding protein enhances PKB
kinase activity and regulates DNA synthesis. J Biol Chem.
280:18525–18535. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang S, Lei Y, Cai Z, Ye X, Li L, Luo X
and Yu C: Girdin regulates the proliferation and apoptosis of
pancreatic cancer cells via the PI3K/Akt signalling pathway. Oncol
Rep. 40:599–608. 2018.PubMed/NCBI
|
11
|
Wang W, Chen H, Gao W, Wang S, Wu K, Lu C,
Luo X, Li L and Yu C: Girdin interaction with vimentin induces EMT
and promotes the growth and metastasis of pancreatic ductal
adenocarcinoma. Oncol Rep. 44:637–649. 2020. View Article : Google Scholar : PubMed/NCBI
|
12
|
Weng L, Enomoto A, Ishida-Takagishi M,
Asai N and Takahashi M: Girding for migratory cues: Roles of the
Akt substrate Girdin in cancer progression and angiogenesis. Cancer
Sci. 101:836–842. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Gu F, Wang L, He J, Liu X, Zhang H, Li W,
Fu L and Ma Y: Girdin, an actin-binding protein, is critical for
migration, adhesion, and invasion of human glioblastoma cells. J
Neurochem. 131:457–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shibata T, Matsuo Y, Shamoto T, Hirokawa
T, Tsuboi K, Takahashi H, Ishiguro H, Kimura M, Takeyama H and
Inagaki H: Girdin, a regulator of cell motility, is a potential
prognostic marker for esophageal squamous cell carcinoma. Oncol
Rep. 29:2127–2132. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ke Y, Bao T, Wu X, Tang H, Wang Y, Ge J,
Fu B, Meng X, Chen L, Zhang C, et al: Scutellarin suppresses
migration and invasion of human hepatocellular carcinoma by
inhibiting the STAT3/Girdin/Akt activity. Biochem Biophys Res
Commun. 483:509–515. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhao Q, Chen XY and Martin C: Scutellaria
baicalensis, the golden herb from the garden of Chinese medicinal
plants. Sci Bull (Beijing). 61:1391–1398. 2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhu PT, Mao M, Liu ZG, Tao L and Yan BC:
Scutellarin suppresses human colorectal cancer metastasis and
angiogenesis by targeting ephrinb2. Am J Transl Res. 9:5094–5104.
2017.PubMed/NCBI
|
18
|
Yang N, Zhao Y, Wang Z, Liu Y and Zhang Y:
Scutellarin suppresses growth and causes apoptosis of human
colorectal cancer cells by regulating the p53 pathway. Mol Med Rep.
15:929–935. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hou L, Chen L and Fang L: Scutellarin
inhibits proliferation, invasion, and tumorigenicity in human
breast cancer cells by regulating HIPPO-YAP signaling pathway. Med
Sci Monit. 23:5130–5138. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kato T, Matsuo Y, Ueda G, Murase H, Aoyama
Y, Omi K, Hayashi Y, Imafuji H, Saito K, Morimoto M, et al:
Enhanced CXCL12/CXCR4 signaling increases tumor progression in
radiation-resistant pancreatic cancer. Oncol Rep. 47:682022.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Deer EL, González-Hernández J, Coursen JD,
Shea JE, Ngatia J, Scaife CL, Firpo MA and Mulvihill SJ: Phenotype
and genotype of pancreatic cancer cell lines. Pancreas. 39:425–435.
2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Omi K, Matsuo Y, Ueda G, Aoyama Y, Kato T,
Hayashi Y, Imafuji H, Saito K, Tsuboi K, Morimoto M, et al: Escin
inhibits angiogenesis by suppressing interleukin-8 and vascular
endothelial growth factor production by blocking nuclear
factor-κB activation in pancreatic cancer cell lines. Oncol
Rep. 45:552021. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shao R and Guo X: Human microvascular
endothelial cells immortalized with human telomerase catalytic
protein: A model for the study of in vitro angiogenesis. Biochem
Biophys Res Commun. 321:788–794. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Francescone RA III, Faibish M and Shao R:
A matrigel-based tube formation assay to assess the vasculogenic
activity of tumor cells. J Vis Exp. 30402011.PubMed/NCBI
|
26
|
Bauer J, Margolis M, Schreiner C, Edgell
CJ, Azizkhan J, Lazarowski E and Juliano RL: In vitro model of
angiogenesis using a human endothelium-derived permanent cell line:
Contributions of induced gene expression, G-proteins, and
integrins. J Cell Physiol. 153:437–449. 1992. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Lánczky A and Győrffy B: Web-based
survival analysis tool tailored for medical research (KMplot):
Development and implementation. J Med Internet Res. 23:e276332021.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Roy S, Miao F and Qi HJ: Cell crawling
assisted by contractile stress induced retraction. J Biomech Eng.
132:0610052010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
Rivas RJ and Hatten ME: Motility and
cytoskeletal organization of migrating cerebellar granule neurons.
J Neurosci. 15:981–989. 1995. View Article : Google Scholar : PubMed/NCBI
|
32
|
Dunkel Y, Ong A, Notani D, Mittal Y, Lam
M, Mi X and Ghosh P: STAT3 protein up-regulates Gα-interacting
vesicle-associated protein (GIV)/Girdin expression, and GIV
enhances STAT3 activation in a positive feedback loop during wound
healing and tumor invasion/metastasis. J Biol Chem.
287:41667–41683. 2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Dunkel Y, Diao K, Aznar N, Swanson L, Liu
L, Zhu W, Mi XY and Ghosh P: Prognostic impact of total and
tyrosine phosphorylated GIV/Girdin in breast cancers. FASEB J.
30:3702–3713. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Leyme A, Marivin A and Garcia-Marcos M:
GIV/Girdin (Gα-interacting, vesicle-associated protein/Girdin)
creates a positive feedback loop that potentiates outside-in
integrin signaling in cancer cells. J Biol Chem. 291:8269–8282.
2016. View Article : Google Scholar : PubMed/NCBI
|
35
|
Simpson F, Martin S, Evans TM, Kerr M,
James DE, Parton RG, Teasdale RD and Wicking C: A novel
hook-related protein family and the characterization of
hook-related protein 1. Traffic. 6:442–458. 2005. View Article : Google Scholar : PubMed/NCBI
|
36
|
Gupta V, Bhandari D, Leyme A, Aznar N,
Midde KK, Lo IC, Ear J, Niesman I, López-Sánchez I, Blanco-Canosa
JB, et al: GIV/Girdin activates Gαi and inhibits Gαs via the same
motif. Proc Natl Acad Sci USA. 113:E5721–E5730. 2016. View Article : Google Scholar : PubMed/NCBI
|
37
|
Jiang P, Enomoto A, Jijiwa M, Kato T,
Hasegawa T, Ishida M, Sato T, Asai N, Murakumo Y and Takahashi M:
An actin-binding protein Girdin regulates the motility of breast
cancer cells. Cancer Res. 68:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Ghosh P, Tie J, Muranyi A, Singh S,
Brunhoeber P, Leith K, Bowermaster R, Liao Z, Zhu Y, LaFleur B, et
al: Girdin (GIV) expression as a prognostic marker of recurrence in
mismatch repair-proficient stage II colon cancer. Clin Cancer Res.
22:3488–3498. 2016. View Article : Google Scholar : PubMed/NCBI
|
39
|
Tanouchi A, Taniuchi K, Furihata M,
Naganuma S, Dabanaka K, Kimura M, Watanabe R, Kohsaki T, Shimizu T,
Saito M, et al: CCDC88A, a prognostic factor for human pancreatic
cancers, promotes the motility and invasiveness of pancreatic
cancer cells. J Exp Clin Cancer Res. 35:1902016. View Article : Google Scholar : PubMed/NCBI
|
40
|
Lu J, Zhang L, Zhou H, Du Z and Zhang G:
Silencing of Girdin suppresses the malignant behavior of colorectal
carcinoma cells. Oncol Rep. 40:887–894. 2018.PubMed/NCBI
|
41
|
Pan B, Shen J, Cao J, Zhou Y, Shang L, Jin
S, Cao S, Che D, Liu F and Yu Y: Interleukin-17 promotes
angiogenesis by stimulating VEGF production of cancer cells via the
STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep.
5:160532015. View Article : Google Scholar : PubMed/NCBI
|
42
|
Wang H, Zhang J, Zhang M, Wei L, Chen H
and Li Z: A systematic study of Girdin on cell proliferation,
migration and angiogenesis in different breast cancer subtypes. Mol
Med Rep. 16:3351–3356. 2017. View Article : Google Scholar : PubMed/NCBI
|
43
|
Benckert C, Thelen A, Cramer T, Weichert
W, Gaebelein G, Gessner R and Jonas S: Impact of microvessel
density on lymph node metastasis and survival after curative
resection of pancreatic cancer. Surg Today. 42:169–176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Zhang Z, Ji S, Zhang B, Liu J, Qin Y, Xu J
and Yu X: Role of angiogenesis in pancreatic cancer biology and
therapy. Biomed Pharmacother. 108:1135–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
45
|
Annese T, Tamma R, Ruggieri S and Ribatti
D: Angiogenesis in pancreatic cancer: Pre-clinical and clinical
studies. Cancers (Basel). 11:3812019. View Article : Google Scholar : PubMed/NCBI
|